About 39 Trademarks found that are filed by the law firm Jeffrey J Ellison

Research and development in the field of medical uses of psychedelic drugs

Research and development in the field of medical uses of psychedelic drugs

PHARMACEUTICAL RESEARCH AND DEVELOPMENT IN THE FIELD OF NEUROLOGY

Providing personalized healthcare and medical information in the area of fibrosis and inflammation

Providing scientific information in the field of synthetic cartilage technology and implant systems for diseased and damaged joints

The color(s) blue and grey is/are claimed as a feature of the mark.

Pharmaceuticals for the treatment of neurological disorders, namely, Parkinson's Disease

Adjuvants for use with vaccines; Animal feed additives and supplements; Anti-infective products for veterinary use; Anti-inflammatories; Dietary, nutritionals and food supplements; Nutritional supplements for general health and well-being; Dietary food supplements for general health and well-being; Medicated dermatological preparations and substances; Medicated skin care preparations; Non-medicated additives for animal feed for use as nutritional supplements; Nutritional supplements for supporting immune function; Nutritional supplements for cats, dogs, horses, livestock; Pharmaceutical preparations for treatment of infectious diseases, namely, respiratory infections, eye infections; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations and substances for the treatment of viral, respiratory, gastrointestinal, dermatological, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of bacteria-based diseases or disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment of bacterial infections; Pharmaceutical preparations for the treatment of bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections; Pharmaceutical preparations for the prevention and treatment of disorders of the immune system, Pharmaceutical preparations for treatment of respiratory diseases, disorders and infections; Pharmaceutical preparations for the treatment of inflammatory disorders and diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in gastroenterology; Pharmaceutical products for skin care for animals; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for treating respiratory diseases; Veterinary preparations for treatment of intestinal bacteria; Veterinary pharmaceutical preparations for animals and poultry to give newborn animals and birds a healthy start; Veterinary pharmaceutical preparations for respiratory and reproductive diseases in cattle; Veterinary pharmaceutical preparations for treatment of bacterial infections in dogs; Veterinary pharmaceutical preparations for the treatment of infectious diseases in poultry; Veterinary pharmaceutical preparations for treatment of infectious disease, namely, respiratory infections, eye infections, topical infections; Veterinary pharmaceutical preparations for the treatment of infectious diseases, namely, swine dysentery, bacterial enteritis, bluecomb, pneumonia; Veterinary pharmaceutical preparations for the treatment of swine bacterial infectious diseases; Veterinary pharmaceutical preparations for treatment of intestinal bacteria

Investment consultation; investment advisory services; financial consulting and advising in the field of mergers and acquisitions

Business consulting services; marketing consulting services; acquisition and merger consultation; business acquisition consultation

Preparations for the treatment of anxiety and depression, none of which are comprised of Cannabis sativa L, or any oils, extracts or derivatives thereof, with a delta-9 tetrahydrocannabinol (THC) content of more than 0.3 percent on a dry weight basis